CoGenesys, Inc.

---

CoGenesys, Inc.

Type	Incorporated
Traded as	NASDAQ: CoGenesys
ISIN	🆔
Industry	Biotechnology
Founded 📆	2005
Founder 👔
Headquarters 🏙️	Rockville, Maryland, U.S.
Area served 🗺️
Key people	CEO Craig A. Rosen, PhD, Founder Steven C. Mayer, EVP, Finance & COO Mark Kirschbaum, MD, CMO
Products 📟	Develops peptide Protein-basedCardiovascularFadraciclib (formerly CYC065), CYC140
Net income	US$ 19.1 million (2021)
Members
Number of employees	50-300 (2021)
🌐 Website	http://www.cogenesys.com
📇 Address
📞 telephone

CoGenesys, Inc. is a biopharmaceutical company that manufactures products. The Company develops peptide and protein-based medicines for cancer, cardiovascular, metabolic, infectious, autoimmune, and CNS diseases. It operates in Rockville, Maryland, United States. CoGenesys was founded in 2005 by Steven C. Mayer, PhD.

References

*

Precigen Names Rutul R. Shah Chief Operating Officer

• Teva earlier this year paid $400 million for CoGenesys.
• CoGenesys, Inc. Announces Worldwide License Agreement With Vegenics Limited, Date 2006
• Teva Takes A Hit On CoGenesys, Date 2008
• CoGenesys Raises $55 Million in Series A Financing

• Profile Company CoGenesys At Bloomberg

External links

• CoGenesys, Inc.Official Website

This article "CoGenesys" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:CoGenesys. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.

📰 Article(s) of the same category(ies)

• Heap (company)
• College Ave Student Loans
• P&L Transportation
• MVBEMG
• Vultr
• Vox Space (launch service provider)
• AppleOne

---